Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477014![]() (US10882844, Example 1030) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477028![]() (US10882844, Example 2006) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474518![]() (US10882844, Example 1001) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474556![]() (US10882844, Example 1016) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477026![]() (US10882844, Example 2003) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474566![]() ((S)-1-(2-(4-carboxycyclohexyl)benzo[d]oxazol-5-yl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477027![]() (US10882844, Example 2004) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477031![]() (US10882844, Example 2009) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477037![]() (US10882844, Example 2015) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474561![]() (US10882844, Example 1020) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477039![]() (US10882844, Example 2017) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474547![]() (US10882844, Example 1012) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474557![]() (US10882844, Example 1017) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.590 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474543![]() (US10882844, Example 1008) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.670 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477010![]() (US10882844, Example 1027) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477012![]() (US10882844, Example 1029) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474565![]() (US10882844, Example 1024) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474559![]() (US10882844, Example 1018) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474554![]() (US10882844, Example 1014) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474548![]() (US10882844, Example 1013) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474546![]() (US10882844, Example 1011) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474545![]() (US10882844, Example 1010) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474544![]() (US10882844, Example 1009) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474542![]() (US10882844, Example 1007) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474541![]() (US10882844, Example 1006) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474538![]() (US10882844, Example 1005) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474536![]() (US10882844, Example 1004) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474535![]() (US10882844, Example 1003) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477040![]() (US10882844, Example 2018) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474534![]() (US10882844, Example 1002) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477036![]() (US10882844, Example 2014) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477032![]() (US10882844, Example 2010) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477038![]() (US10882844, Example 2016) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477035![]() (US10882844, Example 2013) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477033![]() (US10882844, Example 2011) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477030![]() (US10882844, Example 2008) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477029![]() (US10882844, Example 2007) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477024![]() (US10882844, Example 2001) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477034![]() (US10882844, Example 2012) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474562![]() (US10882844, Example 1021) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474560![]() (US10882844, Example 1019) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477025![]() (US10882844, Example 2002) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474555![]() (US10882844, Example 1015) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477023![]() (US10882844, Example 1031) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474563![]() (US10882844, Example 1022) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 105 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477009![]() (US10882844, Example 1026) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.01E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM474564![]() (US10882844, Example 1023) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.01E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand/protein 1 (Homo sapiens-Homo sapiens (Human)) | BDBM477011![]() (US10882844, Example 1028) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.01E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of the extracellular domains of the two proteins. The PD-1 and... | US Patent US10882844 (2021) BindingDB Entry DOI: 10.7270/Q26113F8 | |||||||||||
More data for this Ligand-Target Pair |